{"artifact":{"id":"paper-fig-88c46e91-48d0-4f1a-82f0-be0b1797f885-3","artifact_type":"paper_figure","entity_ids":"[]","title":"FIGURE 3: ZYSD prevention improved cardiac function in isoproterenol‐induced rats with isc...","quality_score":0.5,"created_by":"paper_figures_pipeline","provenance_chain":"[{\"source\": \"paper\", \"paper_id\": \"88c46e91-48d0-4f1a-82f0-be0b1797f885\", \"relation\": \"extracted_from\"}]","content_hash":"2df89a68e340bdf5f62f61f8976ff2698aa6f8cab3a6296ccb89a3bec53d2def","metadata":{"doi":"10.1002/fsn3.71798","pmcid":"PMC13092805","_origin":{"url":"https://www.ebi.ac.uk/europepmc/articles/PMC13092805/bin/FSN3-14-e71798-g001.jpg","type":"external","tracked_at":"2026-04-27T06:18:09.962912"},"caption":"ZYSD prevention improved cardiac function in isoproterenol‐induced rats with ischemic myocardial infarction. (A) Ejection fraction of the rat hearts in the pre‐intervention experiment. (B) Fractional shortening of the rat hearts in the pre‐intervention experiment. (C) Levels of creatine kinase (CK) in the serum of rats in the pre‐intervention experiment. (D) Levels of creatine kinase‐MB (CK‐MB) in the serum of rats in the pre‐intervention experiment. (E) Representative images of myocardial sections stained with hematoxylin and eosin (H&E); the total magnification is 200×; scale bar = 100 μm. The  p  values were determined by one‐way analysis of variance (ANOVA) with Fisher's least significant difference analysis. Data presented as mean ± s.e.m.  n  = 6 for PreNC, PreMC, PreHZ, and PrePC;  n  = 5 for PreLZ and PreMZ.","paper_id":"88c46e91-48d0-4f1a-82f0-be0b1797f885","image_url":"https://www.ebi.ac.uk/europepmc/articles/PMC13092805/bin/FSN3-14-e71798-g001.jpg","image_path":"","description":"","figure_label":"FIGURE 3","figure_number":3,"_schema_version":1,"source_strategy":"pmc_api","entities_mentioned":""},"created_at":"2026-04-26T23:18:09.963089-07:00","updated_at":"2026-04-26T23:18:09.963089-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"external","origin_url":"https://www.ebi.ac.uk/europepmc/articles/PMC13092805/bin/FSN3-14-e71798-g001.jpg","lifecycle_changed_at":"2026-04-26T23:18:09.963089-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"c9e607b6-0072-4ca3-9fc2-3d83729706bc","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"paper_figures_pipeline"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[],"current_artifact_id":"paper-fig-88c46e91-48d0-4f1a-82f0-be0b1797f885-3","is_canonical":true,"supersede_chain":["paper-fig-88c46e91-48d0-4f1a-82f0-be0b1797f885-3"]}